Antiphospholipid antibodies in patients with autoimmune blistering disease
スポンサーリンク
概要
- 論文の詳細を見る
Objective: Our purpose was to determine the serum levels and frequency of antiphospholipid antibodies (aPLs) and confirm the clinical importance of these antibodies in patients with autoimmune blistering disease (ABD). Methods: IgG and IgM anticardiolipin antibodies (aCL), IgG anticardiolipin-β2 glycoprotein I complex antibody (aCL/β2GPI), and IgG antiphosphatidylserine-prothrombin complex antibody (aPS/PT) were examined with an enzyme-linked immunosorbent assay in 71 patients with ABD, including pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid. Results: The prevalence of IgG aCL, IgM aCL, aCL/β2GPI, and IgG aPS/PT was positive for 22.4%, 9.1%, 9.9%, and 25.4% of the ABD patients, respectively, whereas these antibodies were not detected in any of the normal control subjects. Ten of 20 patients with ABD who were attending our hospital in 2004 tested positive for aPLs, and thromboembolism was detected in 7 of 10 patients with aPLs. Limitations: Follow-up studies, especially with a large patient group, will be needed to clarify the clinical relevance of aPLs in ABD. Conclusion: aPLs are frequently detected in patients with ABD. Careful examination and follow-up for thromboembolism may be necessary in ABD patients with aPLs. © 2007 American Academy of Dermatology, Inc.
論文 | ランダム
- ホンダにおける燃料電池車の開発と新型燃料電池車 (特集 燃料電池車の開発最前線)
- ホンダにおける燃料電池車「FCX」の開発 (緊急特集 トヨタとホンダが発売した燃料電池車)
- ホンダにおける燃料電池車の開発 (特集 燃料電池車の開発最前線)
- ホンダの開発する燃料電池自動車 (特集 自動車用燃料電池開発の最新動向)
- スプラウトピンによる上腕骨近位端骨折の治療経験